Ovarian cancer

You have access
Prognostic Value of Tertiary Lymphoid Structures in Epithelial Ovarian Carcinoma
TAKEHIRO NAKAO, KENICHI HARANO, MASASHI WAKABAYASHI, TETSURO TAKI, REIKO WATANABE, HIROSHI TANABE and TORU MUKOHARA

Anticancer Research December 2025, 45 (12) 5543-5555; DOI: https://doi.org/10.21873/anticanres.17889
You have access
Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study
ERIKO TAKATORI, TADAHIRO SHOJI, AMI JO, MIKU MUSASHI, SHUNSUKE TATSUKI, NANAKO JONAI, YOHEI CHIBA, SHO SATO, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, FUMIAKI TAKAHASHI, TAKESHI AIDA and TSUKASA BABA

Anticancer Research December 2025, 45 (12) 5773-5783; DOI: https://doi.org/10.21873/anticanres.17910
Open Access
Focused Ultrasound-mediated Disruption of Plasma Protein Binding Enhances Chemotherapeutic Effects of Paclitaxel on Xenografted Ovarian Cancer in Mice
SEUNG-SCHIK YOO, KATHRYN BANISH, ABDUELRAHMAN FAHMI, CAROLYN GLASENER, KYUNGHO YOON, SWATI BETHARIA, YONGZHI ZHANG, KEVIN ELIAS and NEIL HOROWITZ

Anticancer Research November 2025, 45 (11) 4697-4715; DOI: https://doi.org/10.21873/anticanres.17820
Open Access
Survival Outcomes Post-secondary Cytoreduction in Peritoneal Metastatic Cases from Ovarian Cancer: A Single Institute Study
SHOMA BARAT, NIMA AHMADI, RUWANTHI WIJAYAWARDANA, WINSTON LIAUW and DAVID MORRIS

Anticancer Research October 2025, 45 (10) 4281-4293; DOI: https://doi.org/10.21873/anticanres.17779
You have access
Matrix Metalloproteinase-1 as an Independent Prognostic Biomarker in Epithelial Ovarian Carcinoma
KOHEI HIKINO, HIROAKI KOMATSU, YASUHIRO KAZUKI, KANAKO KAZUKI, KOJI YAMAMOTO, MASAYO OKAWA, YUKI IIDA, MAYUMI SAWADA, GENKI HICHIWA, SHINYA SATO, HIROYUKI KUGOH, MITSUO OSHIMURA, TASUKU HARADA and FUMINORI TANIGUCHI

Anticancer Research October 2025, 45 (10) 4473-4481; DOI: https://doi.org/10.21873/anticanres.17795
Open Access
Comparative Antitumor Efficacy and Toxicity Profile of SCC5, An Ag(I) N-Heterocyclic Carbene Complex, Relative to Platinum-based Chemotherapeutics
JOSEPH A. BAUER, ANNETTE M. SYSEL and MICHAEL J. DUNPHY

Anticancer Research September 2025, 45 (9) 3629-3637; DOI: https://doi.org/10.21873/anticanres.17727
You have access
Efficacy and Prognostic Factors of Surgical Resection for Pulmonary Metastases From Ovarian Cancer
YO TSUKAMOTO, TAKASHI OHTSUKA, YOSHIKANE YAMAUCHI, MINGYON MUN, HARUHISA MATSUGUMA, HIROSHI HASHIMOTO, HIROKI FUKUDA, ICHIRO YOSIHNO, YASUSHI SHINTANI and MASAFUMI KAWAMURA

Anticancer Research May 2025, 45 (5) 2071-2078; DOI: https://doi.org/10.21873/anticanres.17581
Open Access
NEAT1 in Ovarian Cancer: A Key Regulator of Tumor Progression, Follicular Fluid Dynamics, and Therapeutic Resistance
YUN-CHIEH WU, MIN-HSI KU, WEI-LUN HUANG, LUIZA DIAS and CHI-WEI CHEN

Anticancer Research March 2025, 45 (3) 825-842; DOI: https://doi.org/10.21873/anticanres.17472
Open Access
Ovarian Adult Granulosa Cell Tumors: A Scoping Review of DNA Alterations and Their Known Significance
SVEN KARSTENSEN, KARSTEN KAISER, TIM SVENSTRUP POULSEN, KIRSTEN JOCHUMSEN, CLAUS HØGDALL, NIELS MARCUSSEN, FINN FRIIS LAUZSUS and ESTRID HØGDALL

Anticancer Research January 2025, 45 (1) 1-10; DOI: https://doi.org/10.21873/anticanres.17388
Open Access
Gene Expression Profiles in Ovarian Cancer Tissues as a Potential Tool to Predict Platinum-based Chemotherapy Resistance
MELANIJA TALIJANOVIC, JOANNA LOPACINSKA-JØRGENSEN and ESTRID V. HØGDALL

Anticancer Research January 2025, 45 (1) 11-26; DOI: https://doi.org/10.21873/anticanres.17389

Main menu

User menu

Search

Ovarian cancer

Pages